Company,SEDAR_url,mailAddress,contactName,bizEmail,telNum,faxNum,dateForm,jurisdiction,industryClass,cusipNum,finYearEnd,hqAddress,principalRegulator,shortFormProspectusIssuer,reportJurisdiction,stockExchange,stockSym,auditor,generalPartner,transferAgent,assets
,,,,,,,,,,,,,,,,,,,,,
,,"202
1201 - 5th Street SW
Calgary, Alberta
T2R 0Y6",Trevor Peters,t.peters@biocantechnologies.com,403 669-4848,,Oct 22 2014,Alberta,other,,Dec 31,"202
1201 5th Street SW
Calgary, Alberta
T2R 0Y6",Non-Reporting Issuer,No,Non-Reporting Issuer,N/A,,KPMG LLP,,N/A,"Under $5,000,000"
BioCapital Investments Limited Partnership,https://www.sedar.com/DisplayProfile.do?lang=EN&issuerType=03&issuerNo=00005143,"3690 rue de la Montagne
Montreal, Quebec
H3G 2A8",Normand Balthazard,,514 288-0128,514 288-0130,May 8 1997,Quebec,financial services - investment companies and funds,,Dec 31,"3690 rue de la Montagne
Montreal, Quebec
H3G 2A8",No filing is or has previously been made under the MRRS Prospectus Policy,No,Ceased Reporting,TSX,,"Arthur Andersen & Cie, S.E.N.C.",BioCapital Management Inc.,Montreal Trust Company,"$25,000,001 to $100,000,000"
